These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24687549)

  • 1. CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects.
    Ying H; Wang J; Gao X
    Tumour Biol; 2014 Jun; 35(6):5895-904. PubMed ID: 24687549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.
    Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M
    Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis.
    Lee YH; Song GG
    J Recept Signal Transduct Res; 2015; 35(6):509-15. PubMed ID: 25203595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.
    Tsai HT; Yang SF; Chen DR; Chan SE
    Med Oncol; 2012 Dec; 29(4):2771-9. PubMed ID: 22374185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
    Zhou TB; Jiang ZP; Zhou JF; Su N
    Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of chemokine ligand 5/chemokine receptor 5 gene promoter polymorphisms with diabetic microvascular complications: A meta-analysis.
    Zhang Z; Zhang X; Dong J; Gao W; Liu F; Zhao J; Wu X; Guan X; Liu J; Liao L
    J Diabetes Investig; 2016 Mar; 7(2):212-8. PubMed ID: 27042273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
    Song GG; Lee YH
    Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CCL5 and CCR5 gene polymorphisms with periodontitis in Taiwanese.
    Shih YS; Fu E; Fu MM; Lin FG; Chiu HC; Shen EC; Chiang CY
    J Periodontol; 2014 Nov; 85(11):1596-602. PubMed ID: 25119558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5 rs2107538 Polymorphism Increased the Risk of Tuberculosis in a Sample of Iranian Population.
    Kouhpayeh HR; Taheri M; Baziboroon M; Naderi M; Bahari G; Hashemi M
    Prague Med Rep; 2016; 117(2-3):90-97. PubMed ID: 27668525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between CCL5, CCL11, and CCL17 polymorphisms and atopic dermatitis risk: A systematic review and meta-analysis.
    Zou C; Zhang W; Li M; He D; Han Y; Liu M; Lu M
    Medicine (Baltimore); 2024 Feb; 103(8):e36897. PubMed ID: 38394497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.
    Xia W; Xu Y; Mao Q; Dong G; Shi R; Wang J; Zheng Y; Xu L; Jiang F
    Med Oncol; 2015 Feb; 32(2):442. PubMed ID: 25603950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction].
    Xu X; Wang LH; Liu HB; Xu CF; Zhang P; Yong F; Shi YP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
    Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between
    Li J; Peng Y; Liu H; Wu Q
    Oncotarget; 2017 Oct; 8(47):82796-82802. PubMed ID: 29137303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the association between the CC chemokine ligand 5 (CCL5) -403 G>A gene polymorphism and tuberculosis susceptibility.
    Areeshi MY; Mandal RK; Panda AK; Haque S
    PLoS One; 2013; 8(8):e72139. PubMed ID: 24015211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.
    Fu C; Dong WQ; Wang A; Qiu G
    Tumour Biol; 2014 Aug; 35(8):8319-28. PubMed ID: 24859835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine receptor 5 delta32 polymorphism and type 1 diabetes, Behcet's disease, and asthma: a meta-analysis.
    Song GG; Kim JH; Lee YH
    Immunol Invest; 2014; 43(2):123-36. PubMed ID: 24171669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment.
    Baghaei A; Behjati M; Karimian A
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3859-3868. PubMed ID: 36444599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.
    Lee YH; Kim JH; Song GG
    Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.